Page last updated: 2024-11-04

sulpiride and Visceral Pain

sulpiride has been researched along with Visceral Pain in 2 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Visceral Pain: Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.

Research Excerpts

ExcerptRelevanceReference
"The visceral pain was assessed by electrophysiologically measuring the threshold of abdominal muscle contractions in response to colonic distention."1.51Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. ( Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nozu, T2
Miyagishi, S2
Nozu, R1
Takakusaki, K2
Okumura, T2
Kumei, S1
Ohhira, M1

Other Studies

2 other studies available for sulpiride and Visceral Pain

ArticleYear
Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Scientific reports, 2019, 12-20, Volume: 9, Issue:1

    Topics: Animals; Butyrates; Colon; Disease Models, Animal; Electrodes; Hyperalgesia; Inflammation; Irritable

2019
Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats.
    Journal of pharmacological sciences, 2016, Volume: 130, Issue:2

    Topics: Analgesics; Animals; Benzoxazoles; Brain; Consciousness; Injections, Intraventricular; Injections, S

2016